Real-world Study of Lenalidomide After First-line Treatment Lenvatinib With PD-1 in Advanced HCC
Clinical trial NCT07184424 · COMPLETED
Trial details
- NCT number
- NCT07184424
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2025-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.